Centre for Immunity Infection and Evolution, Institute of Immunology and Infection Research, Ashworth Laboratories, School of Biological Sciences, University of Edinburgh, Edinburgh, UK.
Immunology. 2010 May;130(1):92-102. doi: 10.1111/j.1365-2567.2009.03216.x. Epub 2010 Jan 27.
The ultimate outcome of T-cell recognition of peptide-major histocompatibility complex (MHC) complexes is determined by the molecular context in which antigen presentation is provided. The paradigm is that, after exposure to peptides presented by steady-state dendritic cells (DCs), inhibitory signals dominate, leading to the deletion and/or functional inactivation of antigen-reactive T cells. This has been utilized in a variety of models providing peptide antigen in soluble form in the absence of adjuvant. A co-inhibitory molecule of considerable current interest is PD-1. Here we show that there is the opportunity for the PD-1/PD-L1 interaction to function in inhibiting the T-cell response during tolerance induction. Using traceable CD4(+) T-cell receptor (TCR) transgenic cells, together with a blocking antibody to disrupt PD-1 signalling, we explored the roles of PD-1 in the induction of tolerance versus a productive immune response. Intact PD-1 signalling played a role in limiting the extent of CD4(+) T-cell accumulation in response to an immunogenic stimulus. However, PD-1 signalling was not required for either the induction, or the maintenance, of peptide-induced tolerance; a conclusion underlined by successful tolerance induction in TCR transgenic cells genetically deficient for PD-1. These observations contrast with the reported requirement for PD-1 signals in CD8(+) T-cell tolerance.
T 细胞识别肽-主要组织相容性复合物(MHC)复合物的最终结果取决于抗原呈递的分子环境。这一范例是,在暴露于由稳定状态树突状细胞(DC)呈递的肽之后,抑制信号占主导地位,导致抗原反应性 T 细胞的删除和/或功能失活。这已在各种模型中得到利用,这些模型提供了无佐剂的可溶性肽抗原。目前相当关注的一种共抑制分子是 PD-1。在这里,我们表明 PD-1/PD-L1 相互作用有机会在诱导耐受期间抑制 T 细胞反应。我们使用可追踪的 CD4(+)T 细胞受体(TCR)转基因细胞,以及一种阻断抗体来破坏 PD-1 信号,探索了 PD-1 在诱导耐受与产生免疫反应中的作用。完整的 PD-1 信号在限制 CD4(+)T 细胞对免疫原性刺激的积累程度方面发挥了作用。然而,PD-1 信号对于肽诱导的耐受的诱导或维持都不是必需的;这一结论通过在 TCR 转基因细胞中成功诱导耐受得到了强调,这些细胞在 PD-1 基因缺失。这些观察结果与报告的 PD-1 信号在 CD8(+)T 细胞耐受中的作用要求形成了对比。